Foster & Motley Inc. Sells 1,806 Shares of Encompass Health Co. (NYSE:EHC)

Foster & Motley Inc. cut its position in Encompass Health Co. (NYSE:EHC) by 9.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 17,921 shares of the company’s stock after selling 1,806 shares during the period. Foster & Motley Inc.’s holdings in Encompass Health were worth $1,537,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in Encompass Health by 1.7% during the 1st quarter. Vanguard Group Inc. now owns 10,166,147 shares of the company’s stock worth $839,520,000 after buying an additional 169,113 shares during the period. Wellington Management Group LLP grew its position in shares of Encompass Health by 5.8% in the 4th quarter. Wellington Management Group LLP now owns 8,215,770 shares of the company’s stock valued at $548,156,000 after purchasing an additional 449,230 shares during the period. TD Asset Management Inc increased its stake in Encompass Health by 16.0% during the 1st quarter. TD Asset Management Inc now owns 2,283,674 shares of the company’s stock worth $188,586,000 after purchasing an additional 314,488 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Encompass Health by 6.7% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 1,928,449 shares of the company’s stock worth $128,666,000 after buying an additional 120,527 shares during the period. Finally, Brown Advisory Inc. lifted its stake in Encompass Health by 6.2% in the fourth quarter. Brown Advisory Inc. now owns 1,791,517 shares of the company’s stock valued at $119,530,000 after buying an additional 104,847 shares in the last quarter. 97.25% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Encompass Health news, CFO Douglas E. Coltharp sold 12,260 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the completion of the sale, the chief financial officer now directly owns 136,227 shares in the company, valued at $11,761,839.18. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 2.10% of the stock is currently owned by insiders.

Encompass Health Stock Down 0.2 %

Encompass Health stock opened at $93.38 on Friday. The company has a debt-to-equity ratio of 1.08, a current ratio of 1.35 and a quick ratio of 1.35. The company’s 50-day moving average is $88.54 and its 200-day moving average is $83.90. The firm has a market capitalization of $9.40 billion, a PE ratio of 25.24, a P/E/G ratio of 1.42 and a beta of 0.88. Encompass Health Co. has a fifty-two week low of $57.55 and a fifty-two week high of $94.38.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Monday, August 5th. The company reported $1.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.10. The firm had revenue of $1.30 billion for the quarter, compared to analyst estimates of $1.30 billion. Encompass Health had a return on equity of 17.83% and a net margin of 7.88%. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.95 earnings per share. Sell-side analysts anticipate that Encompass Health Co. will post 4.17 earnings per share for the current year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date is Tuesday, October 1st. This is a boost from Encompass Health’s previous quarterly dividend of $0.15. Encompass Health’s dividend payout ratio (DPR) is currently 18.38%.

Analyst Ratings Changes

EHC has been the topic of several research reports. Stephens reaffirmed an “overweight” rating and issued a $105.00 price objective on shares of Encompass Health in a research report on Tuesday, August 6th. Leerink Partnrs upgraded Encompass Health to a “strong-buy” rating in a report on Wednesday, July 10th. Leerink Partners initiated coverage on Encompass Health in a research note on Wednesday, July 10th. They issued an “outperform” rating and a $100.00 target price on the stock. Truist Financial raised their price target on shares of Encompass Health from $100.00 to $104.00 and gave the stock a “buy” rating in a research note on Thursday, August 15th. Finally, Royal Bank of Canada boosted their price objective on shares of Encompass Health from $83.00 to $95.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 22nd. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, Encompass Health has an average rating of “Buy” and a consensus target price of $100.38.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.